Mutational Spectrum and Clinical Outcomes of Myelodysplastic/Myeloproliferative Neoplasms: A Single-Institution Study in Korea with Emphasis on U2AF1

Biochemistry, Genetics and Molecular Biology

• ASXL1 100%
• Overall Survival 50%
• Next Generation Sequencing 50%
• Wild Type 50%
• High Risk Population 50%
• Molecular Model 50%
• Mutated Genes 50%
• Thrombocytosis 50%
• SF3B1 50%

Medicine and Dentistry

• Myeloproliferative Neoplasm 100%
• Chronic Myelomonocytic Leukemia 33%
• Univariate Analysis 16%
• ASXL1 16%
• Prognostic Factor 8%
• Overall Survival 8%
• Next Generation Sequencing 8%
• High Risk Population 8%
• Scoring System 8%
• Myelodysplastic Syndrome 8%
• Neutrophilia 8%
• Bone Marrow Examination 8%
• Molecular Model 8%
• Thrombocytosis 8%